HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 316 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $234,166 | +10.5% | 6,130 | +4.3% | 0.00% | 0.0% |
| Q2 2023 | $211,911 | +89.9% | 5,875 | +101.1% | 0.00% | +100.0% |
| Q1 2023 | $111,591 | -32.3% | 2,922 | +0.8% | 0.00% | -33.3% |
| Q4 2022 | $164,953 | +43.4% | 2,899 | 0.0% | 0.00% | +50.0% |
| Q3 2022 | $115,000 | -10.2% | 2,899 | 0.0% | 0.00% | -33.3% |
| Q2 2022 | $128,000 | +10.3% | 2,899 | 0.0% | 0.00% | +50.0% |
| Q1 2022 | $116,000 | +13.7% | 2,899 | +14.6% | 0.00% | 0.0% |
| Q4 2021 | $102,000 | -1.0% | 2,530 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $103,000 | -10.4% | 2,530 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $115,000 | +9.5% | 2,530 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $105,000 | +356.5% | 2,530 | +377.4% | 0.00% | – |
| Q4 2020 | $23,000 | -72.0% | 530 | -83.1% | 0.00% | -100.0% |
| Q3 2020 | $82,000 | -23.4% | 3,133 | -21.7% | 0.00% | 0.0% |
| Q2 2020 | $107,000 | -25.2% | 4,000 | -63.6% | 0.00% | -60.0% |
| Q1 2017 | $143,000 | +31.2% | 11,000 | 0.0% | 0.01% | +25.0% |
| Q4 2016 | $109,000 | -18.0% | 11,000 | 0.0% | 0.00% | -33.3% |
| Q3 2016 | $133,000 | +40.0% | 11,000 | 0.0% | 0.01% | +50.0% |
| Q2 2016 | $95,000 | -8.7% | 11,000 | 0.0% | 0.00% | -20.0% |
| Q1 2016 | $104,000 | -45.5% | 11,000 | 0.0% | 0.01% | -50.0% |
| Q4 2015 | $191,000 | +29.1% | 11,000 | 0.0% | 0.01% | +25.0% |
| Q3 2015 | $148,000 | -40.3% | 11,000 | 0.0% | 0.01% | -27.3% |
| Q2 2015 | $248,000 | +58.0% | 11,000 | 0.0% | 0.01% | +57.1% |
| Q1 2015 | $157,000 | +25.6% | 11,000 | -15.4% | 0.01% | +16.7% |
| Q4 2014 | $125,000 | +5.9% | 13,000 | 0.0% | 0.01% | 0.0% |
| Q3 2014 | $118,000 | – | 13,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |